Clinical trials recruiting for Tislelizumab
4
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| SBRT combined with Tislelizumab followed by Tislelizumab | 2 |
| Adjuvant therapy | 1 |
| CRT+PD-1 inhibitor+Probio-M9 | 1 |
| Neoadjuvant therapy | 1 |
Self-screener
Recruiting trials
- Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
- Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
- Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
- Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study
Related conditions
Trials recruiting for Tislelizumab often also study these conditions. Each links to its own recruiting-trial list.
Non-small cell lung cancer 507Lung cancer 2180Chemotherapy 25Rectal Cancer, Adenocarcinoma 4Neoadjuvant Therapy 23Nab-paclitaxel 3Immunotherapy 40Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Tislelizumab trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.